API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216463
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215315
https://www.europeanpharmaceuticalreview.com/news/173469/uk-recall-of-clinigens-mexiletine-hydrochloride-hard-capsules/
https://www.prnewswire.com/news-releases/senores-pharmaceuticals-inc-announces-the-launch-of-mexiletine-hydrochloride-capsules-usp-150-mg-200-mg-and-250-mg-with-one-of-the-top-generic-pharmaceutical-companies-in-the-us-market-301469562.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214089
https://www.globenewswire.com/news-release/2020/12/08/2141074/0/en/Scottish-Medicines-Consortium-approves-Lupin-s-NaMuscla-mexiletine-to-treat-symptomatic-myotonia-in-adults-with-non-dystrophic-myotonic-disorders-NDM.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213500
https://www.prnewswire.com/news-releases/lannett-launches-mexiletine-hcl-capsules-301098574.html
https://www.prnewswire.com/news-releases/ani-pharmaceuticals-announces-launch-of-mexiletine-hydrochloride-capsules-301085595.html
https://www.ema.europa.eu/documents/product-information/namuscla-epar-product-information_en.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-european-commission-nod-for-myotonia-treatment-drug/articleshow/67434286.cms
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-15-18-october-2018
https://www.ema.europa.eu/documents/press-release/first-treatment-rare-inherited-muscle-contraction-disorders_en.pdf
https://markets.businessinsider.com/news/stocks/lupin-neurosciences-announces-positive-chmp-opinion-for-namuscla-for-the-treatment-of-myotonia-in-non-dystrophic-myotonic-disorders-1027633591
http://www.fiercepharmaasia.com/story/idt-australia-release-fda-nod-23-generics-begs-question-wheres-beef/2015-04-14